CW June 2000

category image Volume 9
Issue Number 6
June 2000
ISSN 10593802

Herceptin/Taxol Weekly in Metastatic Breast Cancer

Increasing the frequency of administration of Taxol (paclitaxel) in patients who are also receiving Herceptin (trastuzumab) for metastatic breast cancer may provide advantages over current treatment regimens using the two drugs.
Go to Previous Page

Source & Additional Reading

Reports from ASCO Meeting.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW June 2000

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login